Senior Director, Global Skin Cancer Life Cycle Management (LCM) LeadThe Senior Director, Global Skin Cancer Life Cycle Management (LCM) Lead is a member of the Oncology Business Unit at Regeneron, responsible for leading life cycle management strategy and planning for all in-line oncology assets within the Skin Cancer tumor area. This leader is a highly strategic, business-focused expert who assesses opportunities and threats for brands in a fast-paced, complex market. This role reports directly to the Executive Director of Global Skin Cancer Marketing. The LCM Lead will collaborate closely with cross-functional teams and support the overall strategic goals of the portfolio, playing a critical role in Commercial/Clinical cross-functional forums. This individual needs to have strong communication and collaboration skills and will be involved with leading activities across indications. Based on business needs, support of programming and process across total brand indications is required, which includes managing timelines and eliciting content from the Lung franchise for overall deliverable completion. Examples of select content includes summary reports and planning documents that are applicable across brand indications which are evaluated on a case-by-case basis. On site in Sleepy Hollow, NY for 4 days a week.
Discover Your Role:
Facilitate development of and evolution of the global life cycle management strategy (e.g., indication sequencing, geographic expansion) for all in-line oncology assets with Skin Cancer indications to maintain competitive advantage. Shape asset plans within Skin Cancer indications in coordination with the Executive Director of Global Skin Cancer Marketing, Regulatory, Clinical, Competitive Intelligence (CI), and other cross-functional partners; partner with US and international marketers to inform and align on the LCM plan. Maintain up-to-date tumor landscape outlooks for our portfolio and potential competitors in relevant current and future areas, working with Clinical, CI, and Commercial Insights. Share current CI with Global, US, and international marketers and country teams; develop global action plans for competitive threats to be implemented at the country level; develop and deliver related content (e.g., action memos on competitor approvals).Support the Executive Director of Global Skin Cancer Marketing in developing the Commercial perspective for Skin Cancer assets in decision-making forums (e.g., Commercial/Clinical cross-functional committees) and cross-tumor planning meetings; help prepare for these meetings and support follow-up actions. Lead the Marketing team's efforts to plan cross-functionally for new indication launches from early development through pre-launch readiness, following established internal processes including identifying working groups cross functionally and across global and country/international teams to facilitate plans and decisions Inform Medical Affairs and related teams of key data needs and future development plans the organization will support. Develop business analyses/cases for Business Development purposes, for assessing indication trials, and for senior management reviews. Serve as the key Marketing point of contact for the Business Development team on Skin Cancer strategy. Contribute to labeling review team preparations, providing commercial insights to inform labeling decisions. Analyze customer insights, monitor brand performance and competitive dynamics, and translate findings into marketing strategy to address customer needs. Leverage customer feedback through formal and informal channels (e.g., advisory boards, KOL meetings at congresses, market research, field intelligence) to shape strategy and competitive differentiation. Serve as a member of the cross-functional team that develops and delivers the annual US/Global brand plan, including brand strategy, tactical plans, and budget. This Role Requires: Bachelor's degree required; PhD, PharmD, or MBA preferred.12+ years of progressive experience in pharmaceutical marketing, brand strategy, and execution. Oncology experience preferred; Skin cancer experience is a plus. Demonstrated ability to lead strategically, drive performance, build alignment, inform, negotiate, and collaborate. Strong scientific acumen with deep knowledge of oncology; ability to understand, partner with, and provide commercial input to all functions within the project team. Expertise in early- and late-stage life cycle management for pharmaceutical products, including in competitive environments. Previous in-line product and/or indication launch experience required. Experience with global, US, or country marketing and pre-approval planning of oncology and/or buy-and-bill drugs required. Proven track record of market analysis and identifying growth opportunities on a global scale. Ability to synthesize inputs from external and internal collaborators such as HCPs, field teams, country marketers, and market access colleagues. Effective written and oral communication; experience delivering complex messages to diverse internal and external collaborators with a track record of influential presentations. Ability to communicate and act promptly; demonstrated initiative and creativity; and the agility to work effectively in complex, rapidly changing environments. Strong project and process management skills, with the ability to manage multiple tasks and effectively prioritize. Proven standout colleague with the ability to navigate cross-functionally. Strong analytical skills, both quantitative and qualitative. Demonstrated track record of commercial success in roles with progressive responsibilities.
